Brind.

Morgan Stanley downgraded bioMérieux shares on July 7, 2026.

2 reports, 1 independent Updated Jul 25

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Morgan Stanley downgraded bioMérieux shares on July 7, 2026.

Who's involved

What this event is mainly about

bioMérieux Morgan Stanley

Keep exploring

The entities involved

bioMérieux
French company specialised in in vitro diagnostics

Nothing else this week.
Morgan Stanley
U.S. investment bank
- Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

Morgan Stanley downgraded the stock rating for Qfin Holdings, Inc. on September 9, 2026.Sep 9

Coverage

Newest first; wire copies grouped

Jul 7themarketsdaily.com

1 more outlet ran the same wire story

Jul 25dailypolitical.com